drugset / Trial / NCT00603252

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

NCT00603252

Phase 4 Completed 213 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

This protocol posting describes the booster phase of the study. The objectives \& outcome measures of the primary phase are presented in a separate protocol posting (NCT number = NCT00289731).

Timeline

Start
2008-01
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Engerix-B Vaccine
Subject HBVAXPRO Vaccine
Subject Havrix Vaccine
Subject Twinrix Vaccine
Subject Vaqta Vaccine